Sign up for information about our clinical trial for children and adolescents with 22qDS

Nobias is launching a clinical trial of a new potential treatment for children and adolescents who have 22q11.2 deletion syndrome plus inattention, anxiety, or difficulty with social interactions.  If you would like us to contact you with more details, please fill in your information below and click the Submit button. You may also read our brochure.

Fields marked with an asterisk (*) are required.
Thank you - your submission has been received. We will contact you soon at the email address you provided.
Oops! Something went wrong while submitting the form.